Get the app!
Back to Trades

Cheng Andrew

InsiderCIK 0001778307

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
12
Buy transactions
0
Sell transactions
10
Companies
4
Active
2025–2026

Cheng Andrew accounts for 12 disclosed filings worth $53.2M, spread across 4 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $6.0M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

12 loaded
Aug 13DMRA
Damora Therapeutics, Inc.
Cheng AndrewInsiderAward$940.9K
Aug 13DMRA
Damora Therapeutics, Inc.
Cheng AndrewInsiderOther$0
Aug 4TCGX
TCGX Acquisition Corp.
Cheng AndrewInsiderOther$0
May 26VERA
Vera Therapeutics, Inc.
Cheng AndrewInsiderAward$586.8K
Dec 9AKRO
Akero Therapeutics, Inc.
Cheng AndrewInsiderDisposed$44.2M
Nov 21AKRO
Akero Therapeutics, Inc.
Cheng AndrewInsiderGift$0
Nov 13AKRO
Akero Therapeutics, Inc.
Cheng AndrewInsiderGift$0
Oct 14AKRO
Akero Therapeutics, Inc.
Cheng AndrewInsiderSell$1.6M
Oct 9AKRO
Akero Therapeutics, Inc.
Cheng AndrewInsiderExercise$64.2K
Sep 12AKRO
Akero Therapeutics, Inc.
Cheng AndrewInsiderSell$1.4M
Aug 13AKRO
Akero Therapeutics, Inc.
Cheng AndrewInsiderSell$1.5M
Jul 11AKRO
Akero Therapeutics, Inc.
Cheng AndrewInsiderSell$1.5M

12 filings